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ABSTRACT 
Adaptive CD8 T cell immunity is the principal arm of the cellular alloimmune 
response, but its development requires help. This can be provided by CD4 T cells that 
recognise alloantigen ‘indirectly’, as self-restricted allopeptide, but this process 
remains unexplained, because the target epitopes for CD4 and CD8 T cell recognition 
are ‘unlinked’ on different cells (recipient and donor antigen presenting cells (APCs), 
respectively). Here, we test the hypothesis that the presentation of intact and 
processed MHC class I alloantigen by recipient dendritic cells (the ‘semi-direct’ 
pathway) allows linked help to be delivered by indirect-pathway CD4 T cells for 
generating destructive cytotoxic CD8 T cell alloresponses. We show that CD8 T cell-
mediated rejection of murine heart allografts that lack haematopoietic APCs requires 
host secondary lymphoid tissue (SLT). SLT is necessary because within it, recipient 
dendritic cells can acquire MHC from graft parenchymal cells and simultaneously 
present it as intact protein to alloreactive CD8 T cells and as processed peptide 
alloantigen for recognition by indirect-pathway CD4 T cells. This enables delivery of 
essential help for generating cytotoxic CD8 T cell responses that cause rapid allograft 
rejection. In demonstrating the functional relevance of the semi-direct pathway to 
transplant rejection, our findings provide a solution to a long-standing conundrum as 
to why SLT is required for CD8 T cell allorecognition of graft parenchymal cells, and 
suggest a mechanism by which indirect-pathway CD4 T cells provide help for 
generating effector cytotoxic CD8 T cell alloresponses at late time points after 
transplantation. 
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SIGNIFICANCE STATEMENT 
 
Cytotoxic CD8 T cell responses against mismatched MHC class I alloantigen are the 
principal arm of the cellular response against a transplanted organ. How CD4 T cells 
deliver essential help for development of these cytotoxic responses remains unclear. 
Here we show that recipient dendritic cells present acquired MHC alloantigen both 
as intact protein, for recognition by cytotoxic CD8 T cells, and as processed 
allopeptide, for recognition by helper CD4 T cells. Our findings suggest a mechanism 
by which help is provided for generating effector cytotoxic CD8 T cell alloresponses 
at late time points after transplantation, and solve a long-standing conundrum as to 
why host lymphoid tissue is required for CD8 T cell allorecognition of graft 
parenchymal cells. 
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INTRODUCTION 
Cytotoxic CD8 T cell responses directed against MHC Class I alloantigens are one of 
the principal mediators of acute allograft rejection 1, 2. Exceptionally, at very high 
precursor frequency, cytotoxic CD8 T cells can effect graft rejection autonomously 3, 
but generally, differentiation of naïve CD8 T cells to fully functional cytotoxic effector 
cells capable of mediating acute allograft rejection requires help from activated CD4 
T cells. How such help is delivered remains unclear. Studies of conventional CD8 T 
cell responses against non-transplant antigens have demonstrated that CD4 T cell 
help does not involve cognate cell-surface interaction between the helper CD4 T cell 
and cytotoxic CD8 T cell, but that instead, help is delivered to an intermediary 
antigen presenting cell (APC), which is then licensed to prime CD8 T cells 4-6. A critical 
requirement for such help is the expression of both the CD4 and CD8 T cell epitopes 
on the same APC, and an analogous three-cell cluster model (Figure 1A) in 
transplantation is only possible if help for CD8 T cells is provided by CD4 T cells that 
recognise intact MHC class II alloantigen on the surface of donor APC, via the so-
called direct-pathway 7. Murine studies have confirmed that restricting CD4 T cell 
help to the direct pathway generates strong cytotoxic CD8 T cell alloresponses that 
effect rapid allograft rejection 8. 
The indirect-pathway of allorecognition, whereby CD4 T cells recognise processed 
alloantigen as self-restricted allopeptide 7, 9, is now viewed as being at least as 
important as  the direct pathway for initiating and mediating allograft rejection. This 
partly reflects the unique ability of indirect-pathway CD4 T cells to act as helper T 
cells for generating sophisticated alloantibody responses 10, but it is now also clear 
that effective cytotoxic CD8 T cell responses can be generated when CD4 T cell help 
is restricted exclusively to the indirect-pathway 11. This is surprising, because the 
delivery of indirect-pathway T cell help is only readily explained by postulating the 
unlikely formation of a cumbersome four-cell cluster, comprising CD4 and CD8 T 
lymphocytes and both recipient and donor APC (Figure 1b); a cluster in which there 
are no apparent cell surface ligands to enable physical linkage between the donor 
APC / recipient CD8 T cell couplet and the recipient APC / CD4 T cell couplet. This 
raises concerns of potentially uncontrolled CD8 T cell alloimmunity, because such 
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‘unlinked’ help could in principle be provided by concurrent exposure to any 
unrelated antigen. 
The appreciation that many types of cells, but particularly DCs, can capture 
(‘trogocytose’) membrane fragments from other cells 12, 13 has prompted the 
proposal that cytotoxic CD8 T cell alloimmunity may be initiated by a ‘semi-direct’ 
pathway, whereby intact donor MHC class I alloantigen is recognised after its 
acquisition onto the surface of recipient DCs. In support, murine studies have 
detailed in vivo capture of membrane alloantigen by host cells 14, 15. This 
phenomenon provides a possible mechanism by which the same recipient APC as re-
presents intact MHC class I alloantigen could simultaneously present processed 
allopeptide for recognition by indirect-pathway CD4 T cells. This would enable 
formation of a linked three-cell cluster (Figure 1c) that obviates many of the 
concerns associated with the above four-cell cluster model. However, although we 
have recently demonstrated simultaneous presentation of intact and processed 
alloantigen by recipient DCs following heart transplantation 16, the contribution of 
trogocytosis of alloantigen to graft rejection has yet to be clarified. To have 
functional relevance, presentation of intact donor alloantigen by recipient APCs 
must, at least in certain circumstances, be more effective for triggering cytotoxic 
alloimmunity than conventional encounter on donor APCs, and this has not been 
shown. Addressing this key concern is challenging, because it requires development 
of an experimental model in which CD8 T cell allorecognition of target MHC class I 
alloantigen is limited to the surface of recipient, but not donor, APCs. One way this 
could perhaps be achieved is by resolving the paradox created by the seminal 
observations that CD8 T cells can still effect allograft rejection when target MHC 
class I alloantigen is expressed by graft parenchyma only 17, but that rejection of 
vascularised allografts does not occur in the absence of secondary lymphoid tissue 
18. Why secondary lymphoid tissue (SLT) is necessary for CD8 T cell allorecognition of 
graft parenchymal cells has not been explained, but one elegant and compelling 
solution is that alloreactive CD8 T cell activation occurs in lymphoid tissue because 
shed, intact MHC class I alloantigen is only presented by recipient APCs at these 
sites.  
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Here, we show that rejection of heart allografts in mice lacking haematopoietic APCs 
is mediated by alloreactive CD8 T cells, and that the participation of CD8 T cell is 
dependent upon the acquisition and presentation of intact MHC Class I alloantigen 
by recipient DCs within host SLT. We further demonstrate that re-presentation of 
intact alloantigen enables the delivery of essential help from indirect-pathway CD4 T 
cells. These findings provide strong functional support for the provision of indirect-
pathway CD4 T cell help to alloreactive CD8 T cells via a ‘linked’ three-cell cluster 
model.   
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RESULTS 
The requirement for secondary lymphoid tissue for differentiation of effector 
cytotoxic CD8 T cell alloimmune responses 
Key to the proposed ‘semi-direct’ pathway for generating CD8 T cell alloimmunity is 
presentation of intact MHC Class I alloantigen by recipient APCs. In the expectation 
that this presentation would occur chiefly within host SLT, we first sought to 
determine under what circumstances lymphoid tissue was required for effector CD8 
T cell activation and cardiac allograft rejection, by incorporating alymphoplastic 
(aly/aly) mice that lack lymph nodes and Peyer’s patches due to a point mutation in 
the NF-kB-inducing kinase gene 19. We also incorporated TCR-transgenic Rag1-/- 2C 
TCR (2C) mice, whose CD8 T cells recognise H-2Ld alloantigen 20, in the anticipation 
that when present at high frequency, 2C CD8 T cell activation would not require T 
cell help, and that this would, for the initial set of experiments, eliminate the 
confounding role of SLT in initiating helper CD4 T cell responses.  
As previously reported 18, splenectomised aly/aly H-2b mice did not reject BALB/c 
cardiac allografts (Figure 2a). However, increasing the precursor frequency of the 
alloreactive CD8 T cell population in the recipients by adoptive transfer of 2C CD8 T 
cells into the splenectomised aly/aly recipients restored prompt rejection of BALB/c 
heart grafts (median survival time (MST) = 10 days, Figure 2a). We reasoned that the 
rapid graft rejection mediated by 2C CD8 T cells without a requirement for SLT 
reflected the ability of the transferred 2C CD8 T cells to interact with professional 
donor APCs bearing target MHC Class I alloantigen, perhaps within the parenchyma 
of the heart graft. To test this, heart donors were depleted of haematopoietic APCs 
prior to heart graft retrieval by administering lethal irradiation (Figure s1); a strategy 
that resulted in depletion of all MHC class II-expressing APCs from the graft 
parenchyma, as demonstrated by the inability of heart grafts from irradiated mice to 
provoke direct-pathway CD4 T cell alloresponses (Figure 2b). Heart grafts that were 
depleted of haematopoietic cells were not rejected by recipients that lacked SLT, 
even after adoptive transfer of a 2C CD8 T cell effector population (Figure 2c). In 
contrast, when irradiated BALB/c grafts were transplanted into unmodified Rag1-/- 
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2C TCR mice (that harboured SLT), rapid rejection ensued and strong IFN-γ CD8 T 
cells responses were elicited in the 2C CD8 T cell population (Figure 2c and 2d). The 
inability of the transferred 2C CD8 T cells to effect rejection in SLT-deficient 
recipients was not due to lack of target alloantigen within the irradiated hearts, 
because transfer of activated 2C CD8 T cells provoked rapid heart graft rejection 
(Figure 2c). Similarly, irradiated BALB/c hearts were rejected in wild-type C57BL/6 
(B6) recipients (albeit at a slightly slower tempo than when transplanted into Rag1-/- 
2C TCR mice [Figure 2c]), and provoked an IFN-γ CD8 T cell alloresponse within the 
endogenous CD8 T cell population that, although initially weaker than the response 
provoked by an unmodified BALB/c heart graft, was, by day 12, of similar intensity 
(Figure 2e). Thus, although heart allografts can be rejected in the absence of host 
lymphoid tissue, this is dependent upon the presence of donor haematopoietic APCs 
within the graft, and requires an unusually high precursor frequency of alloreactive 
CD8 T cells; lymphoid tissue is normally required to facilitate productive effector CD8 
T cell alloresponses and for rejection of heart allografts devoid of haematopoietic 
APCs.   
Intact MHC alloantigen is presented by host dendritic cells within SLT 
We hypothesised that the requirement for lymphoid tissue to facilitate CD8 T cell 
mediated rejection of allografts lacking haematopoietic APCs likely reflected a critical 
role for SLT as the site for presentation of alloantigen (either processed or intact) by 
recipient DCs. This was examined by creating CD11c-DTR 21 to B6 bone-marrow 
chimeric recipients (CD11c-DTR-BM), in which it was possible to administer 
diphtheria toxin at high enough doses to induce profound depletion of recipient DCs. 
The CD11c-DTR-BM recipients were reconstituted with an effector 2C CD8 T cell 
population (not on a DTR background and therefore not susceptible to diphtheria 
toxin administration), and also received depleting anti-CD4 mAb, to exclude the 
confounding role for host DCs in activating host CD4 T cells. As expected, CD11c-
DTR-BM mice that were reconstituted with 2C CD8 T cells, but that did not receive 
diphtheria toxin, rejected irradiated BALB/c heart grafts rapidly (MST 13 days; Figure 
3a), with development of moderately strong CD8 T cell alloimmunity (Figure 3b). In 
contrast, depletion of the host DCs prolonged allograft survival significantly (MST 26 
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days, Figure 3a), albeit heart allografts were still rejected, perhaps indicating that 
even high doses of diphtheria toxin do not achieve complete or prolonged 
destruction of the recipient DC population 22, 23. Graft rejection was dependent upon 
the transferred 2C CD8 T cell population, because depletion of CD4 T cells prevented, 
as expected 10, the generation of alloantibody (not shown) and it is notable that CD4 
T cell depleted CD11c-DTR-BM mice that were otherwise unmodified neither 
rejected irradiated BALB/c heart grafts nor mounted IFN-γ CD8 T cell alloresponses 
(Figures 3a and 3b).  
This necessity for host DCs to activate CD4 T cell-independent CD8 T cell 
alloimmunity likely reflects their role in presenting intact MHC class I alloantigen 
acquired from donor cells. In support, although as previously reported 16, we were 
unable to demonstrate acquired MHC class I alloantigen on the surface of host DCs 
following transplantation (not shown), DCs purified from B6 recipients of an 
irradiated BALB/c heart graft, provoked an IFN-γ CD8 T cell response upon transfer 
to secondary naïve B6 mice, albeit this response was weaker than following transfer 
of DCs purified from recipients of unmodified BALB/c heart allografts (figure 3c). In 
addition, whereas in vitro culture of purified naïve B6 CD8 T cells with BALB/c 
endothelial cells generated only minimal CD8 T cell proliferation, the response was 
enhanced by addition of B6 DCs to the culture (Figure 3d), implying that the DCs 
acquired and presented intact MHC class I alloantigen from the BALB/c endothelial 
cells. Hence these in vivo and in vitro data highlight a functional role for presentation 
of intact MHC class I alloantigen on recipient DCs in triggering cytotoxic CD8 T cell 
alloimmunity.  
The presentation of processed alloantigen by host dendritic cells enables delivery 
of indirect-pathway help for generating cytototoxic CD8 T cell alloimmunity.   
The major teleological advantage of presentation of intact MHC class I alloantigen by 
host DCs is the potential for the responding alloreactive CD8 T cells to receive linked 
help via a three-cell cluster from CD4 T cells that simultaneously recognise self-
restricted processed alloantigen presented on the same APC (Figure 1c). Hence, 
although the transfer of large numbers of 2C CD8 T cells in the preceding 
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experiments facilitated examination of the presentation of intact alloantigen by 
recipient DCs, the lack of requirement for CD4 T cell help in initiating this response 
prevented definitive study of the three-cell cluster model. However, it is notable that 
irradiated BALB/c hearts that do not provoke a direct-pathway CD4 T cell response 
are rapidly rejected in WT B6 mice (Figure 2c), provoke strong CD8 T cell 
alloimmunity (Figure 2e), and that rejection in unmodified CD11c-DTR-BM recipients 
is CD4 T cell dependent (Figure 3a). Although these observations suggest a role for 
indirect-pathway CD4 T cells and alloantigen presentation by host DCs in triggering 
effector CD8 T cell alloimmunity, the generation of alloantibody (Figure 4a) from 
preservation of indirect-pathway helper CD4 T cell alloresponses 10 complicates 
interpretation of the contribution of CD8 T cell cytotoxicity to rejection.  
To distinguish the role of alloantigen presentation by host DCs in generating 
cytotoxic CD8 T cell alloimmunity from that of the production of alloantibody, a 
further series of experiments were performed, in which irradiated BALB/c heart 
allografts were transplanted into CD11c-DTR BM chimeric mice as above, and with 
recipient humoral alloimmunity blocked by depletion of host B cells (Figure 4a, 
Figure s2). B cell depletion did not compromise rejection of irradiated BALB/c heart 
allografts by B6 mice (Fig 4b). All grafts were rejected rapidly, with rejection 
dependent upon host CD8 T cells (Figure 4b) and associated with development of 
strong IFN-γ CD8 T cell alloimmunity (Figure 4c). As above (Figures 3a), rejection was 
delayed by ablation of recipient DCs (Figure 4b). Critically, however, host CD4 T cells 
were also required to effect rapid graft loss (Figures 4b and c).  
The graft rejection kinetics, coupled with the CD8 T cell ELISPOT data, strongly 
suggest that the cytotoxic CD8 T cell response is mediating graft rejection, but to 
confirm this, B cell-depleted ‘GzmBCrexRosa26YFP’ H-2b mice 24 were challenged 
with an irradiated BALB/c heart allograft and tamoxifen administered concurrently. 
CD8 T cells in these recipients that differentiate into granzyme B-expressing effector 
cells are indelibly marked with enhanced yellow fluorescence protein (YFP). Ten days 
after transplantation, populations of YFP+ve effector CD8 T cells were readily 
detectable within the spleen and within the rejecting heart allograft (Figure 4d), with 
a higher proportion of recovered CD8 T cells from the heart allograft expressing YFP 
12 
 
(Figure 4e). Similarly, because irradiated heart allografts do not provoke a direct-
pathway CD4 T cell response (Figure 2b), help for cytotoxic CD8 T cells can 
theoretically only be provided by indirect-pathway CD4 T cells. To confirm this, 
Rag2-/- C57BL/6 mice were reconstituted with GzmBCrexRosa26YFP CD8 T cells and 
with TCR75 CD4 T cells that recognise donor H-2Kd alloantigen as self-restricted, 
processed allopeptide exclusively via the indirect pathway. Whereas irradiated 
BALB/c grafts were not rejected in Rag2-/- C57BL/6 recipients reconstituted with 
TCR75 CD4 T cells only (Figure 4f), TCR75 CD4 T cells provided help for differentiating 
effector cytotoxic CD8 T cell responses (Figure 4e) that were responsible for rapid 
allograft rejection (Figure 4f).  
When coupled to the earlier observation that host DCs are essential for CD4 T-cell 
independent 2C CD8 T cell alloresponses (Figures 2c and d), these latter experiments 
provide functional support for the three-cell cluster model and presentation of intact 
MHC class I alloantigen by host cells for generating cytotoxic alloimmunity (Figure 
1c), with linked help provided by indirect-pathway CD4 T cells.  
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DISCUSSION 
The present studies address the important question of how CD4 T cell help is 
provided to alloreactive CD8 T cells for the development of destructive cytotoxic 
responses, and our results help to resolve a long-standing debate on the mechanism 
by which help is delivered by CD4 T cells with indirect allospecificity. The use of 
donor mice deleted of haematopoietic cells, allied to ablation of DCs or absence of 
host SLT enabled us to confirm that in certain circumstances, host DCs were critical 
for priming cytotoxic CD8 T cell responses that effected rapid allograft destruction. 
In doing so, our findings provide a solution to the paradox created by two earlier 
landmark studies that observed that SLT was required for rejection of a vascularised 
allograft 18, but that cytotoxic CD8 T cells could mediate allograft rejection when 
expression of target MHC class I alloantigen was limited to graft parenchyma 17. 
Moreover, because our model was refined to exclude the contribution of alternative 
effector mechanisms of graft rejection, we believe our manuscript is the first to 
demonstrate the functional relevance of the ‘semi-direct’ pathway to transplant 
rejection.  
The means by which immune cells acquire or ‘trogocytose’ membrane proteins from 
other cells are becoming better understood 12. Most data relate to acquisition of 
MHC-peptide complexes from the surface of APC by responding T cells; a process 
dependent upon downstream signalling of the TCR 25. The immunological 
consequences of such trogocytosis are still not clear and may include: increasing 
competition between T cells through reduction in available target MHC / peptide 
epitope; increased T cell activation from continued positive signalling via the 
internalised complexes; and regulatory T cell – T cell interaction. Trogocytosis may 
hold particular relevance for transplantation, because the ability to transfer 
allogeneic membrane proteins between donor and recipient immune cells is likely to 
have more profound consequences than transfer of self-proteins. Nevertheless, few 
studies have reported functional significance for either solid organ or 
haematopoietic stem cell transplantation 26, 27 and our findings thus emphasise the 
potentially important contribution of trogocytosis in initiating adaptive 
alloimmunity. 
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As to why host DCs were required in our experiments for generating CD4 T cell-
independent, cytotoxic 2C CD8 T cell alloresponses to an irradiated heart allograft, 
this presumably reflects that intact MHC class I alloantigen is re-presented by host 
DCs in association with the necessary co-stimulatory ligands for effector 
differentiation of the 2C CD8 T cells. This in turn suggests that the DCs have been 
activated by acquisition of alloantigen. One would perhaps anticipate that DCs would 
only express intact alloantigen for a short period, because of their principal role as 
antigen processors, but retention of soluble, unprocessed antigen within DCs for 
subsequent re-presentation to B cells has been described 28, 29. Whether this 
function is restricted to a particular DC subset is not clear. In any event, even 
transient presentation of intact alloantigen by the host DC may be sufficient to drive 
full effector activation of the alloreactive CD8 T cell fraction, because unlike CD4 T 
cells 30, brief engagement with the CD8 TCR may be sufficient to trigger an ‘autopilot’ 
response 31 and multiple rounds of division 32. 
Although we studied a solid organ transplant model, our findings may be equally 
pertinent to the delivery of CD4 T cell help for development of cellular graft-versus-
host responses following haematopoietic stem cell transplantation. As above, direct-
pathway donor CD4 T cell responses against host will be reliant upon recognition of 
host MHC class II alloantigen on the surface of host professional APCs. Such 
recognition will not occur with ablation of host bone marrow and attainment of full 
haematopoietic chimerism; instead, the dominant pathway for triggering donor CD4 
T cell alloresponses is likely the presentation of processed host alloantigen by donor 
APCs. These indirect-pathway CD4 T cells could theoretically provide ‘linked’ help to 
alloreactive donor CD8 T cells for generating cytotoxic graft versus host responses, 
assuming that target host intact MHC class I alloantigen is first acquired onto the 
surface of the same donor APC as presents processed allopeptide to the helper CD4 
T cell.  
It is striking that host SLT is required for 2C CD8 T cell mediated rejection of 
irradiated heart allografts, but not for rejection of wild-type heart grafts with an 
intact haematopoietic component. This presumably relates to differences in the 
availability of target MHC class I alloantigen; that even in the absence of SLT, the 
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artificially high frequency of TCR-transgenic, alloreactive CD8 T cells can interact 
productively with the large numbers of donor DCs normally released from a heart 
allograft. In contrast, much fewer host DCs are likely to acquire and re-present intact 
MHC class I alloantigen, and SLT may consequently be needed to facilitate their 
encounter with alloreactive CD8 T cells. Whether the recipient DCs capture 
alloantigen within the graft and then transit to the regional lymphoid tissue or 
whether shed alloantigen is acquired by DCs resident within SLT is not clear, and is 
the focus of on-going investigation. 
Our experiments involving WT, non-transgenic CD8 T cell responders demonstrated 
that CD4 T cell help was critical for cytotoxic, effector differentiation. We have 
previously demonstrated simultaneous presentation of intact and processed 
alloantigen by the same DC 16. Within the SLT, this dual presentation presumably 
allows the indirect-pathway helper CD4 T cell to license the DC for effective 
presentation of MHC class I alloantigen to the alloreactive CD8 T cell, that binds 
either simultaneously, or sequentially 4, to the same DC. It is important to 
acknowledge, however, that our experiments do not provide definitive proof of this 
three cell interaction. Our conclusion is based on the observations that host DCs are 
essential for both helper cell-independent CD8 T cell alloresponses against MHC 
class I expressed on parenchymal graft cells, and, when responder CD8 T cell 
numbers are limited, for generating essential indirect-pathway CD4 T cell help. 
Hence our experiments do not exclude the possibility that indirect-pathway CD4 T 
cell help is provided through interaction with one particular host DC subset, while 
the alloreactive CD8 T cells are activated through interaction with another. This 
seems unlikely, because it would again represent an unlinked four-cell cluster, and 
the effectiveness, and control, of CD8 T cell activation is likely to be much greater if 
the helper CD4 T cell and alloreactive CD8 T cell determinants are expressed on the 
same host DC. It would be theoretically possible to visualise this interaction using 
dynamic intravital microscopy 33, but such an approach would neither provide 
information relating to cytotoxic differentiation nor its functional relevance to graft 
rejection. A further outstanding question relates to the manner of indirect-pathway 
CD4 T cell help. It is unclear whether there is the requirement for cell-cell contact, 
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through CD40/CD40L interactions for example, or whether paracrine IL-2 secretion is 
sufficient to provide the necessary help for CD8 T cell activation.  
  
17 
 
MATERIALS AND METHODS 
Animals 
Wildtype (wt) C57BL/6 (B6; H-2b) and BALB/c (H-2d) mice were purchased from 
Charles River Laboratories (Harlow, UK). Bm12 mice - B6(C)-H2-Ab1bm12/KhEgJ (H-
2bm12) and C57BL/6 CD11c-DTR (H-2b) mice 34 were purchased from The Jackson 
Laboratory (Bar Harbor, ME). ALY/NscJcl-aly/aly (aly/aly; H-2b) mice were purchased 
from CLEA Inc. (Japan). TCR transgenic Rag1-/- 2C TCR (2C; H-2b) mice 20 were gifted 
by Geetha Chalasani (University of Pittsburgh, PE). C57BL/6 Rag2-/- mice (H-2b) were 
gifted by Prof T Rabbitts (University of Cambridge, UK). C57BL/6-Tg(Kd)RPb mice 
(B6.Kd; H-2b) that express transgenic H-2Kd were gifted by Dr R.P. Bucy (University of 
Alabama, Birmingham, AL 35). TCR transgenic Rag1-/- TCR75 mice (TCR75; H-2b), 
specific for I-Ab restricted H-2Kd54-68 peptide were gifted by Prof P. Bucy (University 
of Alabama, Birmingham, AL 36). GzmBCrexRosa26YFP (H-2b) mice 24 were gifted by 
Prof D Fearon (University of Cambridge, UK). 
Heterotopic cardiac transplantation  
Vascularised cardiac allografts were transplanted intra-abdominally using the 
technique of Corry and colleagues37. Splenectomy was performed in aly/aly recipient 
mice prior to implantation of the donor organ. In experiments involving 
GzmBCrexRosa26YFP mice as recipients or transfer of purified GzmBCrexRosa26YFP  
CD8 T cells, 1mg tamoxifen was administered i.p. to the recipient the day before and 
every second day after transplant. Graft rejection was defined as cessation of 
palpable myocardial contraction, confirmed at explant.  
Purification and adoptive transfer of leucocyte subsets  
2C transgenic CD8 T cells were purified from Rag1-/- 2C TCR mice using an autoMACS 
Separator (Mitenyi Biotec). ‘Activated’ 2C TCR CD8 were obtained by purification 
from Rag1-/- 2C TCR mice challenged one week earlier with a BALB/c heterotopic 
heart graft. For adoptive transfer, 106 purified 2C TCR transgenic CD8 T cells were 
administered i.v. on the day of transplantation. In certain experiments, Rag2-/- mice 
were reconstituted with 105 TCR75 CD4 T cells and 106 GzmBCrexRosa26YFP CD8 T 
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cells, purified from respective host mice using an autoMACS Separator (Mitenyi 
Biotec).  
Dendritic cells were purified from recipient mice spleens four days after 
transplantation with a heart graft and adoptively transferred into naïve secondary 
C57Bl/6 mice as described previously 16. Naïve secondary mice received 3 x 106 cells 
(the approximate total recovered from four recipients) transferred i.v.  
Generation of bone marrow chimeras 
Chimeric mice that were CD11c-DTR+ only in the haematopoietic compartment 
(CD11c-DTR-BM mice) were created by lethally-irradiating C57BL/6 mice (13 Gy in 2 
x 6.5 Gy fractions) and reconstituting with 2 x 107 bone marrow cells from 
C57BL/6.CD11c-DTR mice. Such chimeric mice tolerate high doses of diphtheria toxin 
necessary to induce profound depletion of the DC fraction without developing the 
severe toxicity associated with those doses in standard CD11c-DTR mice 38. 
Chimerism was confirmed by flow cytometric analysis of PBMCs 4 weeks following 
reconstitution. 
Dendritic cell, T and B cell depletion. 
CD11c-DTR-BM chimeric heart graft recipients were treated with i.p. 32ng/g 
diphtheria toxin (List Biological Laboratories Inc. (Campbell, CA) on days -3, -1 and +1 
in relation to transplantation and thrice weekly thereafter. For B cell depletion, 
recipients were treated with 250μg i.p. depleting anti-CD20 mAb (18B12, IgG2a 
gifted by Cherie Butts, Biogen Idec Boston, MA) on day -7 and fortnightly thereafter. 
Because of concerns that CD8 T cells are resistant to treatment with depleting anti 
CD8 mAb 11, combined B and CD8 T cell depletion was instead achieved by 
reconstituting Rag2-/- C57BL/6 mice with C57Bl/6 CD4 T cells, purified using standard 
magnetic bead separation (Mitenyi Biotec).  
Depletion of the haematopoietic cell fraction in donor mice.  
Depletion of haematopoietic cells in donor BALB/c mice was achieved by lethal 
irradiation (13 Gy in 2 x 6.5 Gy fractions) on day -7 and treatment with 1 mg i.p. 
depleting anti-CD4 mAB (rat IgG2b, clone YTS 191.1; hybridoma purchased from 
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European Collection of Cell Cultures at the Health Protection Agency) on day -2 in 
relation to transplantation. Depletion was confirmed by flow cytometric analysis of 
serum and splenic tissue collected at procurement of the heart graft. Absence of 
haematopoietic cells within the heart graft was additionally confirmed by the 
inability of heart grafts from haematopoietic-cell depleted B6.Kd donor mice to 
trigger ‘direct-pathway’ CD4 T cell responses in recipient bm12 mice, as assessed by 
quantifying division of CFSE-labelled TCR75 CD4 T cells seven days after transfer at 
time of transplant. In this model, TCR75 CD4 T cells only recognise target, I-Ab-
restricted H-2Kd peptide epitope on the surface of donor cells; presentation of 
processed, I-Abm12-restricted H-2Kd-peptide by recipient APCs (via the ‘indirect-
pathway’) does not provoke a response 10. 
CFSE CD4 T cell proliferation and Flow cytometry 
Proliferation of TCR75 CD4 T cells was determined by CFSE-labelled cell division at 
day 7 following adoptive transfer, as described previously 10. FITC conjugated CD11c 
(clone HL3), APC conjugated CD4 (clone GK1.5), PE-Cy7 conjugated CD4 (clone 
GK1.5) and PE conjugated CD8 (clone 53-6.7) were purchased from BD Pharmingen 
(San Diego, CA). Peripheral blood and splenic single-cell suspensions were blocked 
with anti-mouse CD16/CD32 (clone 2.4G2) before staining with the relevant Abs and 
dead cell exclusion dye 7-aminoactinomycin (both from BD Pharmingen). 
Biotinylated Abs were detected by allophycocyanin-conjugated streptavidin 
(Invitrogen), and all cells were analyzed on a FACSCanto II flow cytometer with 
FACSDiva software (Becton Dickinson U.K., Oxford, U.K.). 
Endothelial cell culture and in vito CD8 T cell proliferative responses 
In vitro proliferative CD8 T cell responses were assayed by challenging splenic CD8 T 
cells with BALB/c endothelial cells or irradiated (25 Gy) BALB/c splenocytes as 
stimulators. Endothelial cells were obtained by extraction from suspensions of 10 to 
14 day-old neonatal murine hearts by incubation with biotinylated anti-CD31 (clone 
MEC 13.3, BD Pharmingen); CD105 (clone MJ7/18, BioLegend) and Isolectin B4 (clone 
B-1205, Vector). Endothelial cells were then extracted using an autoMACS Separator 
and the resultant cells cultured in flasks pre-coated with 1% Gelatin in standard 
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growth medium (Hepes buffered DMEM with 10% FCS, 100 IU/ml penicillin-
streptomycin, 2mM L-Glutamine) to which Endothelial Cell Growth Factor (E9640, 
Sigma-Aldrich Inc. St Louis, MO) was added. Responders and stimulators were co-
cultured in a 1:1 ratio at 4x105 cells/well for 6 days prior to addition of 1 μCi/well 
[3H]thymidine for 6 hours. Cells were then harvested and [3H]thymidine 
incorporation measured. 
Assay of circulating anti-H-2Kd alloantibody and CD8 T cell ELISPOT.  
Serum samples were collected from experimental mice at intervals and analysed for 
the presence of anti–H-2Kd IgG alloantibody by ELISA as previously described 10. For 
each sample, an absorbance vs. dilution curve was plotted, and the area under the 
curve calculated 39 and expressed as the percentage of positive control (pooled 
hyperimmune) serum. CD8 T cell ELISPOT was performed as described 40.  
Statistical analysis  
Data were presented as mean ± SEM where appropriate. Mann-Whitney-U test was 
used for analysis of nonparametric data. Graft survival was depicted using Kaplan-
Meier analysis and groups compared by log-rank (Mantel-Cox) testing. Analysis was 
conducted using GraphPad 4 (Graph- Pad Software, San Diego, CA, USA). Values of P 
< 0.05 were considered significant. 
Study approval 
Mice were bred and maintained in specific-pathogen-free animal facilities and all 
experiments were approved by the United Kingdom Home Office under the Animal 
(Scientific Procedures) Act 1986. All mice were 6–10 weeks of age at the beginning of 
the experiments. 
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Figure 1: Possible mechanisms for provision of CD4 T cell help to alloreactive CD8 T 
cells.  
Analogous to provision of CD4 T cell help for cytotoxic CD8 T cell responses against 
nominal protein antigen, simultaneous linked ‘direct-pathway’ allorecognition of 
MHC class I and class II alloantigen on donor antigen presenting cells (APCs) by 
cytotoxic CD8 and helper CD4 T cells, respectively, is considered the dominant helper 
mechanism (a). Nevertheless, indirect-pathway CD4 T cells that recognise self-
restricted alloantigen following internalisation and processing by recipient APCs can 
also provide help; an ‘unlinked’ four cell-cluster model has been proposed (b). 
Provision of linked help by indirect pathway CD4 T cells may be achieved by a three 
cell cluster model in which the recipient APC simultaneously presents intact and 
processed MHC Class I alloantigen to, respectively, the cytotoxic CD8 T cell and 
helper CD4 T cell (c).  
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Figure 2: Secondary lymphoid tissue is normally required for differentiation of 
effector cytotoxic CD8 T cell alloimmunity. 
(a) Whereas, BALB/c heart allografts are not rejected in splenectomised, 
alymphoplastic (aly/aly) H-2b mice, rapid rejection was restored by adoptive transfer 
of H-2Ld-reactive ‘2C-TCR’ CD8 T cells at transplantation. (b) Heart allografts were 
depleted of haematopoietic cells by treating donor animals with a combination of 
lethal irradiation and anti-CD4 mAb. Depletion was confirmed by comparing 
proliferation of CFSE-labelled TCR75 CD4 T cells, adoptively transferred into bm12 
recipients at transplant with B6.Kd heart allografts procured from either naïve or 
lethally-irradiated donor mice: lower panel – representative flow cytometric division 
profiles; top panel – percentage of parent cells undergoing at least one division 
cycle. In this model, TCR75 CD4 T cells recognise H-2Kd peptide complexed to I-Ab on 
donor cells, but do not recognise recipient I-Abm12-restricted antigen. (c) Kaplan 
Meier survival analysis of heart allografts from irradiated BALB/c donors 
transplanted into wild-type C57BL/6 (B6), or Rag1-/- 2C TCR, or splenectomised 
aly/aly H-2b mice that were adoptively transferred with naïve or activated 2C TCR 
CD8 T cells. (d) Purified 2C CD8 T cells from Rag1-/- 2C TCR recipients of heart 
allografts from un-modified or lethally-irradiated BALB/c donors exhibit similar in 
vitro interferon-γ recall ELISPOT responses against donor (BALB/c) stimulators. (e) 
Interferon-γ recall ELISPOT assay comparison of the cytotoxic CD8 T cell alloresponse 
at early (day 4) and late (day 12) time points after transplantation of B6 mice with 
heart allografts from either naïve or lethally irradiated BALB/c donors. * P < 0.05,** P 
< 0.01, *** P <0.001 (Kaplan Meier in a,c; Mann-Whitney test in b,d,e). Data are 
representative of two independent experiments resulting in at least n=4 in each 
group. 
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Figure 3: The generation of CD4 T-cell independent CD8 T cell alloimmunity 
requires host dendritic cells.  
Heart allografts from lethally-irradiated BALB/c donors were transplanted into CD4 T 
cell depleted ‘CD11c-DTR-BM’ recipients. Control mice received no additional 
treatment, whereas experimental mice were adoptively transferred with Rag1-/- 2C 
CD8 T cells alone (2C CD8), or in combination with high-dose diphtheria toxin (2C 
CD8 +DT) to ablate host DCs. (a) Kapan-Meier survival analysis. (b) Minimal CD8 T 
cell alloresponses, as assayed by IFN-γ ELISPOT, were observed in CD4 T cell 
depleted (but otherwise unmodified) CD11c-DTR-BM recipients of irradiated BALB/c 
heart allografts (control). These were significantly augmented by adoptive transfer of 
Rag1-/- 2C CD8 T cells (2C CD8). This augmentation was dependent upon the host DC 
population (2C CD8 +DT; * P < 0.05). Included for reference are the typical cytotoxic 
CD8 T cell responses generated in WT C57BL/6 (B6) recipients of irradiated BALB/c 
grafts (WT B6). (c) Four days after transplantation with heart allografts from WT (WT 
donor) or irradiated BALB/c (irrad donor) donors, CD11c DCs were purified from B6 
recipient spleens and adoptively transferred into naïve, secondary B6 hosts. 
Cytotoxic CD8 T cell alloimmunity in the secondary hosts was assayed 10 days after 
transfer as above; included as control are the responses observed in naïve B6 mice. 
Individual data points represent responses observed in individual mice. (d) The 
response of purified B6 CD8 T cells to in vitro challenge with BALB/c splenocytes 
(SPC) or cultured BALB/c endothelial cells (EC) was quantified by standard mixed 
lymphocyte thymidine-incorporation assay. Responses to endothelial cell challenge 
were significantly increased by addition of B6 DC to culture. *P <0.05, ** P < 0.01, *** P 
<0.001. (Kaplan Meier in a; Mann-Whitney test in b,c,d). Data are representative of 
two independent experiments resulting in at least n=6 in each group. 
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Figure 4: The generation of cytotoxic effector alloresponses within the endogenous 
CD8 T cell repertoire requires host DCs and help from indirect-pathway CD4 T cells.  
(a) Anti-H-2Kd alloantibody responses in C57BL/6 (B6) recipients of heart allografts 
from lethally-irradiated BALB/c donors (irrBALB/c) are similar in magnitude to those 
generated following transplantation with unmodified BALB/c heart allografts ( P = 
NS), and abrogated by B cell depletion. BALB/c heart grafts devoid of haematopoietic 
APCs were transplanted into B cell depleted CD11c-DTR-BM B6 recipients that were 
additionally depleted of either DCs (CD20-veDC-ve) or CD4 T cells (CD20-veCD4-ve). 
Combined B and CD8 T cell-deficient recipients (CD20-veCD8-ve) of irradiated BALB/c 
heart allografts were created by reconsituting Rag2-/- B6 mice with purified B6 CD4 T 
cells. Control CD11c-DTR-BM B6 recipients were depleted of B cells only (CD20-ve). 
Graft survival was assessed by Kaplan Meier analysis (b) and CD8 T cell alloimmunity 
quantified by IFN-γ ELISPOT (c). To evaluate effector CD8 T cell differentiation, CD20-
depleted GzmBCrexRosa26YFP H-2b mice were transplanted with irradiated BALB/c 
grafts and tamoxifen administered concurrently. Representative flow cytometry 
plots (d) depicting granzyme B positive effector CD8 T cells within the recipient 
spleen and heart allograft, and expressed graphically (e) as percentage of purified 
CD8 T cell. Figure (e) also depicts a similar analysis for Rag2-/- C57BL/6 recipients of 
irradiated BALB/c heart allografts that were reconstituted with GzmBCrexRosa26YFP 
CD8 T cells and with indirect-pathway TCR75 helper CD4 T cells. Limiting CD4 T cell 
help to the indirect pathway resulted in effective CD8 T cell effector differentiation. 
(f) Whereas Rag2-/- C57BL/6 recipients reconstituted with TCR75 CD4 T cells did not 
reject irradiated BALB/c heart allografts, grafts were rejected promptly if an effector 
population of GzmBCrexRosa26YFP CD8 T cells were additionally transferred. * P < 
0.05, ** P < 0.01, *** P <0.001; (Mann-Whitney test in a,c,e; Kaplan Meier in b,f). Data 
are representative of n=4 in d,e,f; and two independent experiments resulting in at 
least n=5 in each group in a,b,c. 
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